Concepedia

Vishal Chandra

VC

Statistics

Publications

11

Citations

361

H-Index

10

Active since

2008

Affiliations

Central Drug Research Institute(Current)

King George's Medical University

Integral University

Institute of Nuclear Medicine & Allied Sciences

Vishal Chandra is an author at Central Drug Research Institute specializing in oncology, medicine, and molecular oncology.

Publications per year

2008–2016

11

Publications

11

(−)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation

Murli Manohar, Iram Fatima, Ruchi Saxena et al. · The Journal of Nutritional Biochemistry · 2012 · 77 citations

Life Sciences, Cell Biology, Pharmacology +9

Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents

Ravi Shankar, Bandana Chakravarti, Uma S. Singh et al. · Bioorganic & Medicinal Chemistry · 2009 · 63 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +12

Phylogeography of mtDNA haplogroup R7 in the Indian peninsula

Gyaneshwer Chaubey, Monika Karmin, Ene Metspalu et al. · BMC Evolutionary Biology · 2008 · 53 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer

Shailesh Kumar, Shreekant Deshpande, Vishal Chandra et al. · Bioorganic & Medicinal Chemistry · 2009 · 32 citations

Pharmacy, Medicinal Chemistry, Oncology +8

Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer

Han‐Seong Kim, Jae‐Soo Koh, Yong‐Bock Choi∥ et al. · PLoS ONE · 2014 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 11